I'm LongbridgeAI, I can summarize articles.Xiao Fang Pharma has signed a cooperation development agreement with Shanghai Dermatology Hospital to jointly develop a new traditional Chinese medicine compound, Cedar Extract, for the treatment of hair loss. This drug has the effects of cooling the blood, promoting circulation, and stimulating hair growth. It has accumulated efficacy and safety data in clinical applications, mainly used for treating various types of hair loss, with broad prospects and is expected to become the first traditional Chinese medicine preparation for hair loss in China
According to the Zhitong Finance APP, Xiao Fang Pharma (603207.SH) announced that the company recently signed a "Cooperative Development Agreement for Compound Platycladus Oil" with Shanghai Dermatology Hospital. The two parties plan to jointly carry out the new drug transformation development of Compound Platycladus Oil, which is a characteristic hospital preparation of Shanghai Dermatology Hospital (Shanghai Drug Preparation No. Z201800070000). It has the effects of cooling blood, promoting qi, and promoting hair growth, mainly used for the treatment of various types of hair loss.
Compound Platycladus Oil is a characteristic hospital preparation of Shanghai Dermatology Hospital, with a reasonable formulation. It has accumulated certain efficacy and safety data in clinical applications, and after repeated clinical verification, its efficacy is confirmed, with a certain research foundation in pharmacy, pharmacology, and toxicology. Its effects include cooling blood, promoting qi, and promoting hair growth, mainly used for the treatment of various types of hair loss. Compound Platycladus Oil has been used for many years to treat various types of hair loss, is well-received by patients, and has good efficacy for androgenetic alopecia and alopecia areata. It has promising development and application prospects and is expected to become the first traditional Chinese medicine preparation for hair loss in China